MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Clinical, radiological and genetic spectrum of fifteen cases of PLA2G6-Associated Neurodegeneration – A Single Centre Cohort from India

    P. Pal, V. Holla, N. Sriram, R. Kumari, P. Phulpagar, S. Kamath, S. Prasad, N. Kamble, J. Saini, R. Mahale, M. Netravathi, H. Padmanabha, V. Gowda, R. Battu, A. Pandey, R. Yadav, B. Muthusamy (Bengaluru, India)

    Objective: To study the clinical, radiological and genetic profile of patients with genetically proven PLA2G6-Associated Neurodegeneration (PLAN). Background: PLAN is a clinically heterogenous genetic disorder…
  • 2023 International Congress

    Examining the association between adverse effects of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor and structural connectivity using probabilistic tractography targets

    E. Tsolaki, K. Fu, Z. Rifi, M. Chodakiewitz, W. Wei, N. Pouratian, A. Bari (Los Angeles, USA)

    Objective: We examine the relationship between adverse effects of MRgFUS thalamotomy in essential tremor (ET) patients and the structural connectivity of the ventral intermediate nucleus…
  • 2023 International Congress

    Tourettism occurring during gender transition with testosterone therapy

    C. Comet, G. Haarman, E. Elowe-Gruau, A. Merglen, P. Burkhard, V. Fleury (Brussels, Belgium)

    Objective: Past decades have seen an increase in gender dysphoria subjects seeking hormonal treatment1,2. We report motor and vocal tics following testosterone therapy introduction for…
  • 2023 International Congress

    Certification for advanced practice providers working in movement disorders expands access to quality expert and specialized care.

    K. Papesh, B. Jones (Fort Collins, USA)

    Objective: Elevate awareness of impact of a professional certification for APPs in PD & movement disorders (PMD), which increases access specialized care, improving outcomes. Demonstrate certification…
  • 2023 International Congress

    Improved Tremor Response to Focused Ultrasound Thalamotomy

    J. Holcomb, R. Chopra, F. Feltrin, M. Elkurd, R. El-Nazer, L. Mckenzie, P. O’Suillebhain, J. Maldjian, W. Dauer, B. Shah (Dallas, USA)

    Objective: This study sought to determine if, when using four tract tractography (FTT) to target the decussating and non-decussating dentatorubrothalamic tracts (DRTTs), essential tremor (ET)…
  • 2023 International Congress

    Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming

    T. Nakamura, H. Nishijima, F. Mori, I. Kinoshita, T. Kon, C. Suzuki, K. Wakabayashi, M. Tomiyama (Hirosaki, Japan)

    Objective: We examined whether levodopa-induced dyskinesia (LID) and axon terminal hypertrophy gradually develop with repeated levodopa treatment in Parkinsonian rats to prove that the hypertrophy…
  • 2023 International Congress

    Disease progression in Parkinson‘s disease patients with Mild Cognitive Impairment: 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

    X. Deng, S. Saffari, S. Ng, N. Chia, X. Choi, D. Heng, B. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, E. Tan, L. Tan (Singapore, Singapore)

    Objective: To investigate motor, non-motor and cognition progression in early PD patients with Mild Cognitive Impairment (MCI) and normal cognition over 5 years.    Background:…
  • 2023 International Congress

    Prognostic impact of frontal-lobe clinical bedside signs in progressive supranuclear palsy

    I. Ruiz Barrio, A. Horta Barba, S. Martinez Horta, J. Kulisevsky, J. Pagonabarraga (Barcelona, Spain)

    Objective: To identify clinical bedside examination signs indicative of frontal lobe dysfunction with a prognostic value in patients with progressive supranuclear palsy (PSP). Background: The…
  • 2023 International Congress

    Quercetin hinders Glial Activation to Alleviate the Cadmium Induced Dopaminergic Alteration via TNFα mediated CAMKIIα/ERK activation

    R. Shukla, V. Khanna, R. Gupta (bahraich, India)

    Objective: The present study has therefore been carried out identify neuroprotective role of quercetin in alleviating the cadmium induced dopaminergic dysfunctions via glial mediated deactivation…
  • 2023 International Congress

    Spinocerebellar ataxia type 28 presenting as spastic paraparesis

    R. Hoe, S. Neo, L. Tan (Singapore, Singapore)

    Objective: To describe a patient with spinocerebellar ataxia type 28 (SCA28) presenting with isolated spastic paraparesis. Background: Autosomal dominant (AD) mutations in the ATPase family…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley